Key Takeaways
- • Akzo Nobel and Elliott Management reach standstill agreement on August 16, 2017, suspending all litigation for at least three months and ending a monthslong activist campaign that threatened board control.
- • Elliott, owning 9.5% of Akzo Nobel, agrees to support new CEO Thierry Vanlancker and two supervisory board member nominations, while Akzo commits to give Elliott input on a third board seat.
- • The settlement represents a major strategic retreat by Elliott after losing two legal battles to convene shareholder meetings to remove Chairman Antony Burgmans, who had rejected PPG Industries' €27 billion ($30.44 billion) takeover offer at 95 euros per share.
- • Elliott secures backing for Akzo's planned divestiture of its Speciality Chemicals division (approximately one-third of sales and profits), a position the hedge fund had consistently advocated for throughout the dispute.
- • Akzo Nobel shares trade at 77.22 euros following the agreement, significantly below PPG's rejected 95 euro per share bid, reflecting ongoing market skepticism about standalone value creation versus a negotiated sale.
Summary
Akzo Nobel N.V. and Elliott Management have resolved their protracted dispute through a standstill agreement announced on August 16, 2017, marking a truce in one of Europe's highest-profile activist investor campaigns. Under the accord, both parties agreed to suspend all ongoing litigation for a minimum of three months, effectively ending Elliott's public assault on Akzo's board and strategy following repeated rejections of acquisition offers from U.S. rival PPG Industries.
The settlement came after Elliott, which holds a 9.5% stake in the Dutch paint and chemicals manufacturer, suffered two consecutive legal defeats in attempting to convene shareholder meetings to remove Chairman Antony Burgmans. The activist hedge fund, led by Gordon Singer as CEO of Elliott Advisors (UK) Ltd., had waged a months-long campaign criticizing Akzo's decision to reject PPG's final offer of 95 euros per share—representing a nearly 50% premium to Akzo's February share price—worth approximately €27 billion in total. Elliott had argued that Akzo's board was breaching fiduciary duties by rebuffing what it characterized as substantial shareholder consideration.
Under the agreement's terms, Elliott secured meaningful board influence without forcing Burgmans' removal. The activist investor agreed to support the nomination of new CEO Thierry Vanlancker and two supervisory board members, while Akzo committed to providing Elliott and other major shareholders a consultative role in naming a third supervisory board seat. Additionally, Elliott obtained explicit backing for Akzo's planned divestiture of its Speciality Chemicals division, a business unit representing approximately one-third of group sales and profits—a position Elliott had consistently supported throughout the dispute.
Despite the settlement, market pricing reflects lingering uncertainty about standalone value creation. Following the announcement, Akzo shares traded at 77.22 euros, substantially below PPG's rejected 95 euro per share offer, suggesting investor skepticism regarding management's ability to unlock equivalent shareholder value through independent operations and the planned asset sale. Gordon Singer characterized the agreement as "an important next step in enabling the company to deliver compelling value to all its stakeholders," framing the truce as a constructive path forward rather than an activist capitulation.
The settlement came after Elliott, which holds a 9.5% stake in the Dutch paint and chemicals manufacturer, suffered two consecutive legal defeats in attempting to convene shareholder meetings to remove Chairman Antony Burgmans. The activist hedge fund, led by Gordon Singer as CEO of Elliott Advisors (UK) Ltd., had waged a months-long campaign criticizing Akzo's decision to reject PPG's final offer of 95 euros per share—representing a nearly 50% premium to Akzo's February share price—worth approximately €27 billion in total. Elliott had argued that Akzo's board was breaching fiduciary duties by rebuffing what it characterized as substantial shareholder consideration.
Under the agreement's terms, Elliott secured meaningful board influence without forcing Burgmans' removal. The activist investor agreed to support the nomination of new CEO Thierry Vanlancker and two supervisory board members, while Akzo committed to providing Elliott and other major shareholders a consultative role in naming a third supervisory board seat. Additionally, Elliott obtained explicit backing for Akzo's planned divestiture of its Speciality Chemicals division, a business unit representing approximately one-third of group sales and profits—a position Elliott had consistently supported throughout the dispute.
Despite the settlement, market pricing reflects lingering uncertainty about standalone value creation. Following the announcement, Akzo shares traded at 77.22 euros, substantially below PPG's rejected 95 euro per share offer, suggesting investor skepticism regarding management's ability to unlock equivalent shareholder value through independent operations and the planned asset sale. Gordon Singer characterized the agreement as "an important next step in enabling the company to deliver compelling value to all its stakeholders," framing the truce as a constructive path forward rather than an activist capitulation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.